EUVIMEDEUVIMED entdecken
Crossref

Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids

Nan Wang, Jing Li, Ze-Xuan Chen, Jie Tang, Xue-Yee Lim, Ling Li iD, Tong Zhang

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Nan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Pudong New District, No 1200, Cai lun Road, Shanghai 201203, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Fatty Acids, Volatile, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Nation Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Leading Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Ling Gui Zhu Gan (LGZG) Granules is a marketed traditional Chinese medicine compound granule, which is formulated to be consistent with the key quality attributes of the traditional LGZG Decoction. The volatile components are important parts of its preparation process.

Methods

A high-fat diet (HFD)-induced Non-alcoholic fatty liver disease (NAFLD) mouse model was established to evaluate the therapeutic effects of LGZG and preparation of LGZG’s volatile components (IC-LGZG). Gut microbiota composition, Short-chain Fatty Acids (SCFA) levels, and intestinal parameters were assessed, and its correlations were analyzed. Lipopolysaccharide-induced RAW264.7 cells tested anti-inflammatory effects. Key findings LGZG and IC-LGZG significantly reduced HFD-induced body weight gain, improved lipid profiles and liver function, restored gut microbiota balance, increased beneficial bacteria (Akkermansia, Bacteroides, Parabacteroides, Dubosiella, and Bifidobacterium) that produce SCFAs, thereby enhancing SCFA concentrations (acetic acid, propionic acid, and butyric acid), decreased harmful bacteria abundance, and strengthened the intestinal barrier. In vitro studies showed that LGZG, IC-LGZG, and cinnamaldehyde exerted anti-inflammatory effects.

Conclusion

LGZG and its volatile components effectively alleviate the progression of NAFLD by modulating the gut microbiota homeostasis and SCFA levels, and can exert anti-inflammatory effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseFatty Acids, VolatileDrugs, Chinese HerbalAnti-Inflammatory AgentsAnimalsMiceRAW 264.7 CellsMaleMice, Inbred C57BLDiet, High-FatDisease Models, AnimalLiver

Stichwörter der Autor:innen

Ling Gui Zhu Gan Granulesintestinal floranon-alcoholic fatty liver diseaseshort-chain fatty acidsvolatile components

Substanzen

Fatty Acids, VolatileDrugs, Chinese HerbalAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Pudong New District, No 1200, Cai lun Road, Shanghai 201203, China.
  • College of Pharmacy, Anhui University of Traditional Chinese Medicine, Yaohai District, No 350, Long zi hu Road, Hefei 230000, China.

ORCID-Profile: Ling Li

Förderung

  • Nation Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Leading Talents Program
  • Shanghai Science and Technology Innovation
  • Shanghai Rising-Star Program

Zitieren

APA

Wang, N., Li, J., Chen, Z. X., Tang, J., Lim, X. Y., Li, L., & Zhang, T. (2025). Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf070

Vancouver

Wang N, Li J, Chen ZX, Tang J, Lim XY, Li L, et al. Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf070

BibTeX
@article{Wang2025,
  author = {Wang, Nan and Li, Jing and Chen, Ze-Xuan and Tang, Jie and Lim, Xue-Yee and Li, Ling and Zhang, Tong},
  title = {Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf070}
}
Kostenlos starten →